Epigenetic Regulation of Human Cis-natural Antisense Transcripts
Overview
Authors
Affiliations
Mammalian genomes encode numerous cis-natural antisense transcripts (cis-NATs). The extent to which these cis-NATs are actively regulated and ultimately functionally relevant, as opposed to transcriptional noise, remains a matter of debate. To address this issue, we analyzed the chromatin environment and RNA Pol II binding properties of human cis-NAT promoters genome-wide. Cap analysis of gene expression data were used to identify thousands of cis-NAT promoters, and profiles of nine histone modifications and RNA Pol II binding for these promoters in ENCODE cell types were analyzed using chromatin immunoprecipitation followed by sequencing (ChIP-seq) data. Active cis-NAT promoters are enriched with activating histone modifications and occupied by RNA Pol II, whereas weak cis-NAT promoters are depleted for both activating modifications and RNA Pol II. The enrichment levels of activating histone modifications and RNA Pol II binding show peaks centered around cis-NAT transcriptional start sites, and the levels of activating histone modifications at cis-NAT promoters are positively correlated with cis-NAT expression levels. Cis-NAT promoters also show highly tissue-specific patterns of expression. These results suggest that human cis-NATs are actively transcribed by the RNA Pol II and that their expression is epigenetically regulated, prerequisites for a functional potential for many of these non-coding RNAs.
Novel insights on the positive correlation between sense and antisense pairs on gene expression.
Das S, Zea Rojas M, Tran E Wiley Interdiscip Rev RNA. 2024; 15(4):e1864.
PMID: 39087253 PMC: 11626863. DOI: 10.1002/wrna.1864.
Liu M, Zhang S, Zhou H, Hu X, Li J, Fu B Theranostics. 2023; 13(8):2616-2631.
PMID: 37215575 PMC: 10196821. DOI: 10.7150/thno.83920.
The Functional Meaning of 5'UTR in Protein-Coding Genes.
Ryczek N, Lys A, Makalowska I Int J Mol Sci. 2023; 24(3).
PMID: 36769304 PMC: 9917990. DOI: 10.3390/ijms24032976.
Ohhata T, Suzuki M, Sakai S, Ota K, Yokota H, Uchida C Sci Rep. 2022; 12(1):15525.
PMID: 36109624 PMC: 9477841. DOI: 10.1038/s41598-022-19782-5.
Complex Transposon Insertion as a Novel Cause of Pompe Disease.
Bychkov I, Baydakova G, Filatova A, Migiaev O, Marakhonov A, Pechatnikova N Int J Mol Sci. 2021; 22(19).
PMID: 34639227 PMC: 8509548. DOI: 10.3390/ijms221910887.